Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02507336 · ClinicalTrials.gov registry record · Phase 2
Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT02507336 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 2 participants.
The verdict
NCT02507336, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The study seeks to provide long-term follow-up and/or to offer continued maintenance thalidomide (THALOMID) therapy to those patients enrolled in 20030165. Patients will be followed until withdrawal of consent, or death.
Interventions
- DRUG Thalidomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-11-24 |
| Est. Completion | 2023-08-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02507336
The ClinicalTrials.gov registry entry for NCT02507336 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thalidomide is the first listed.
NCT02507336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02507336 about?
NCT02507336 is a clinical study titled "Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165". The study seeks to provide long-term follow-up and/or to offer continued maintenance thalidomide (THALOMID) therapy to those patients enrolled in 20030165. Patients will be followed until withdrawal of consent, or death.
What is the current status of trial NCT02507336?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2015-11-24. Estimated completion is 2023-08-02.
What interventions are being tested in trial NCT02507336?
The interventions under investigation include: Thalidomide (DRUG).
Who is sponsoring clinical trial NCT02507336?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.